These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Comparison of clinical and microbiological response to treatment of Clostridium difficile-associated disease with metronidazole and vancomycin. Al-Nassir WN; Sethi AK; Nerandzic MM; Bobulsky GS; Jump RL; Donskey CJ Clin Infect Dis; 2008 Jul; 47(1):56-62. PubMed ID: 18491964 [TBL] [Abstract][Full Text] [Related]
3. Fecal transplant via retention enema for refractory or recurrent Clostridium difficile infection. Kassam Z; Hundal R; Marshall JK; Lee CH Arch Intern Med; 2012 Jan; 172(2):191-3. PubMed ID: 22271132 [No Abstract] [Full Text] [Related]
4. [Clostridium difficile--unfairly set in the corner?]. Benno P; Dahlgren AL; Norin E; Midtvedt T Lakartidningen; 2012 Sep 26-Oct 9; 109(39-40):1775. PubMed ID: 23097893 [No Abstract] [Full Text] [Related]
5. Artificial stool transplantation: progress towards a safer, more effective and acceptable alternative. Allen-Vercoe E; Petrof EO Expert Rev Gastroenterol Hepatol; 2013 May; 7(4):291-3. PubMed ID: 23639085 [No Abstract] [Full Text] [Related]
6. [Clostridium difficile-associated diarrhea treated with homologous feces]. Midtvedt K Tidsskr Nor Laegeforen; 1998 Apr; 118(11):1758. PubMed ID: 9621767 [No Abstract] [Full Text] [Related]
7. The changing face of Clostridium difficile: what treatment options remain? Shen EP; Surawicz CM Am J Gastroenterol; 2007 Dec; 102(12):2789-92. PubMed ID: 18042108 [TBL] [Abstract][Full Text] [Related]
9. [Role of Clostridium difficile infection in the relapse of ulcerative colitis]. Vilalta Castel E; Alcázar Montero MS; Navarro Gaspar C; Gimeno Aranguez M An Med Interna; 2002 Dec; 19(12):637-9. PubMed ID: 12593034 [TBL] [Abstract][Full Text] [Related]
10. Decreased effectiveness of metronidazole for the treatment of Clostridium difficile infection? Kuijper EJ; Wilcox MH Clin Infect Dis; 2008 Jul; 47(1):63-5. PubMed ID: 18491959 [No Abstract] [Full Text] [Related]
11. Outcomes of Clostridium difficile-associated disease treated with metronidazole or vancomycin before and after the emergence of NAP1/027. Pépin J; Valiquette L; Gagnon S; Routhier S; Brazeau I Am J Gastroenterol; 2007 Dec; 102(12):2781-8. PubMed ID: 17900327 [TBL] [Abstract][Full Text] [Related]
17. Absence of pseudomembranes in Clostridium difficile-associated diarrhea in patients using immunosuppression agents. Nomura K; Fujimoto Y; Yamashita M; Morimoto Y; Ohshiro M; Sato K; Oyake T; Kowata S; Konishi H; Yoshikawa T; Ishida Y; Taniwaki M; Scand J Gastroenterol; 2009; 44(1):74-8. PubMed ID: 18781540 [TBL] [Abstract][Full Text] [Related]
18. Metronidazole for Clostridium difficile-associated disease: is it okay for Mom? Gerding DN Clin Infect Dis; 2005 Jun; 40(11):1598-600. PubMed ID: 15889356 [No Abstract] [Full Text] [Related]
19. Beyond mainstream: making the case for fecal bacteriotherapy. Myers F Nursing; 2011 Dec; 41(12):50-3. PubMed ID: 22089910 [No Abstract] [Full Text] [Related]
20. Breaking the cycle: treatment strategies for 163 cases of recurrent Clostridium difficile disease. McFarland LV; Elmer GW; Surawicz CM Am J Gastroenterol; 2002 Jul; 97(7):1769-75. PubMed ID: 12135033 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]